Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02348398
Title Phase II Study of Pazopanib and Topotecan in Cervical Cancer
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

cervical squamous cell carcinoma

cervical adenosquamous carcinoma

cervical adenocarcinoma


Pazopanib + Topotecan

Age Groups: adult
Covered Countries

No variant requirements are available.